Cellular Therapies: Revolutionizing Cancer Therapy
Part 1: Adoptive Cell Therapy - An Introduction

 

Related Videos (117)

In this first of a four-part series describing cellular therapies for hematologic cancers, Carl  H. June, MD, Richard W. Vague Professor in Immunotherapy at Penn Medicine, provides an introduction to current adoptive cell therapies in the hematologic malignancies with a concentration on CAR T cells, and discusses the characteristics of the optimal approach to CAR T therapy.

To view other parts of this program:

Part 2: CTL019 Therapy in Chronic Lymphocytic Leukemia

Part 3: CTL019 in Relapsed Refractory Pediatric Acute Lymphoblastic Leukemia

Part 4: Adoptive Cell Therapy - Lessons Learned, Issues and the Future

 

Penn PhysicianLink®

Penn PhysicianLink® is an exclusive program that helps all referring physicians connect with Penn Medicine. This comprehensive package of support services expedites and facilitates direct physician communication for patient consults, referrals and transfers.

Learn more about Penn PhysicianLink®